Literature DB >> 7579448

The Ser 460 to Pro substitution of the protein S alpha (PROS1) gene is a frequent mutation associated with free protein S (type IIa) deficiency.

J Duchemin1, S Gandrille, D Borgel, P Feurgard, M Alhenc-Gelas, C Matheron, M Dreyfus, E Dupuy, I Juhan-Vague, M Aiach.   

Abstract

A Ser 460 to Pro mutation of protein S (PS), involving a T to C transition in exon XIII of the protein S alpha (PROS1) gene and known as the Heerlen polymorphism, was found in 16 of 85 symptomatic patients with PS deficiency (18.8%) and only 1 of 113 healthy subjects (0.8%). Another frequent polymorphism was described in exon XV of the PROS1 gene, in the codon for Pro 626 (CCA/CCG). We found that Heerlen polymorphism was associated with allele CCA and not with allele CCG, suggesting a probable transmission by a common ancestor. Most subjects bearing the Ser 460 to Pro mutation were deficient in free PS, but had normal total PS levels. Normal levels of the C4b-binding protein (C4b-BP) isoform containing a beta chain (C4b-BP beta +) ruled out increased C4b-BP beta + as a cause of the free-PS deficiency. The binding curves of the mutated (Heerlen) PS on C4b-BP immobilized on microplates were biphasic, suggesting that one molecule of C4b-BP can bind two molecules of Heerlen PS. Because normal PS binds to C4b-BP with 1:1 stoichiometry, this may explain the free-PS deficiency observed in patients carrying the Ser 460 to Pro mutation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579448

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

Review 1.  What causes the antiphospholipid syndrome?

Authors:  J T Merrill
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

2.  PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study.

Authors:  A P Reiner; C L Carty; N S Jenny; C Nievergelt; M Cushman; D J Stearns-Kurosawa; S Kurosawa; L H Kuller; L A Lange
Journal:  J Thromb Haemost       Date:  2008-08-01       Impact factor: 5.824

3.  Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk.

Authors:  P Suchon; M Germain; A Delluc; D Smadja; X Jouven; B Gyorgy; N Saut; M Ibrahim; J F Deleuze; M C Alessi; P E Morange; D A Trégouët
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

4.  Carrier frequencies of antithrombin, protein C, and protein S deficiency variants estimated using a public database and expression experiments.

Authors:  Keiko Maruyama; Koichi Kokame
Journal:  Res Pract Thromb Haemost       Date:  2020-11-27

5.  A Case of Type 2 Protein S Deficiency Presenting as Cerebral Venous Thrombosis (CVT) in an 18-Year-Old Female.

Authors:  Ankush Agarwal S; Jennie Santhanam; Arun K; Sruthi Degapudi; Subramaniyan K
Journal:  Cureus       Date:  2022-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.